13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q2 2024 · Filed August 8, 2024 · Accession 0001766721-24-000004
Total Value
$231.1M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 6,068,125 | $153.7M | 66.52% |
| 2 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,025,000 | $21.0M | 9.11% |
| 3 | Verona Pharma plc (VRNA) | 925050106 | 1,115,352 | $16.1M | 6.98% |
| 4 | Elevation Oncology Inc (ELEV) | 28623U101 | 2,834,910 | $7.7M | 3.31% |
| 5 | Nuvation Bio Inc. (NUVB) | NUVB | 2,541,009 | $7.4M | 3.21% |
| 6 | Compass Pathways Plc (CMPS) | CMPS | 964,500 | $5.8M | 2.52% |
| 7 | Monte Rosa Therapeutics Inc (GLUE) | GLUE | 1,472,331 | $5.5M | 2.38% |
| 8 | Biomea Fusion Inc (BMEA) | BMEA | 798,757 | $3.6M | 1.56% |
| 9 | Poseida Therapeutics Inc. (PSTX) | 73730P108 | 1,043,267 | $3.0M | 1.32% |
| 10 | CalciMedica, Inc. (CALC) | CALC | 521,114 | $2.1M | 0.89% |
| 11 | Marker Therapeutics, Inc. (MRKR) | MRKR | 314,286 | $1.7M | 0.74% |
| 12 | Tectonic Therapeutic Inc (TECX) | TECX | 84,148 | $1.4M | 0.60% |
| 13 | Reneo Pharmaceuticals Inc (RPHM) | 75974E103 | 886,075 | $1.3M | 0.58% |
| 14 | Aclaris Therapeutics Inc (ACRS) | ACRS | 434,455 | $477,901 | 0.21% |
| 15 | Viracta Therapeutics Inc (VIRX) | 92765F108 | 288,571 | $156,896 | 0.07% |